• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Ftorafur

Ftorafur

Product ID F7657
Cas No. 17902-23-7
Purity ≥99%
Product Unit SizeCostQuantityStock
250 mg $111.70 In stock
1 g $296.30 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Ftorafur is an antimetabolite pyrimidine analog that exhibits anticancer chemotherapeutic activity. Ftorafur is a prodrug of 5-fluorouracil that inhibits thymidylate synthase, preventing thymidine synthesis. Ftorafur is typically clinically co-administered with other chemotherapeutics to decrease its peripheral cytotoxicity.

Product Info

Cas No.

17902-23-7

Purity

≥99%

Formula

C8H9FN2O3

Formula Wt.

200.17

Chemical Name

5-Fluoro-1-(tetrahydro-2-furanyl)-2,4(1H,3H)- pyrimidinedione

IUPAC Name

5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione

Synonym

Tegafur, Citofur, Furafluor, 5-Fluoro-1-(tetrahydro-2-furyl)uracil

Melting Point

164-169°C

Solubility

Soluble in hot water, ethanol, methanol, or DMSO.

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

F7657 MSDS PDF

Info Sheet

F7657 Info Sheet PDF

References

Fukushima M. Antitumor activity and function of S-1, a new oral tegafur-based formulation. Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:19-26. PMID: 16897968.

Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003 May;3(5):330-8. PMID: 12724731.

Tanaka F, Fukuse T, Wada H, et al. The history, mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agents. Curr Pharm Biotechnol. 2000 Sep;1(2):137-64. PMID: 11467334.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A8812

    AWD 131-138

    GABA-A positive modulator.

    ≥99%
  • S3346

    Silodosin

    α1A-adrenergic antagonist.

    ≥98%
  • I088240

    (S,S)-ICG-001

    Wnt/β-catenin inhibitor

    ≥98%
  • B3210

    R-Bicalutamide

    AR antagonist.

    ≥98%
  • R1877

    all-trans-Retinol, ≥98 %

    Diterpene vitamin A; RAR/RXR agonist.

    ≥98%
  • P0255

    Pantoprazole

    H+/K+ ATPase and ROCK-2 inhibitor.

    ≥98%
  • K1776

    Ketotifen Fumarate

    H1 histamine and LT antagonist, PDE inhibitor.<...

    ≥98%
  • P8169

    Purpurin

    Anthraquinone pigment found in madder root; O-a...

    ≥90%
  • C344761

    Citalopram Chloromethyl Quaternary Ammonium Chloride

    Citalopram analog

    ≥95%
  • F4680

    Flutamide

    Non-steroid; AR antagonist.

    ≥98%
  • M3377

    Mitomycin C

    Alkaloid produced by Streptomyces, DNA cross-li...

    ≥98%
  • A5228

    Angiogenin

    Small protein, cleaves RNA.

    ≥98%
  • W0247

    Walrycin B

    Walrycin response regulator inhibitor.

    ≥98%
  • Y0002

    Y-320

    Phenylpyrazoleanilide; IL-17 production inhibit...

    ≥98%
  • G5320

    GNF-2

    Abl inhibitor.

    ≥98%
  • C0255

    Cantharidin

    Toxin produced by Canarthis vesicatoria; PP1/2A...

    ≥98%
  • L337521

    Linagliptin

    Modifies microvascular function

    ≥98%
  • C179603

    CEP-37440 Hydrochloride

    Inhibitor of FAK and ALK.

    ≥99%
  • G4581

    Glucosamine Sulfate Potassium Chloride

    Endogenous amino acid sugar involved in cartila...

    ≥98%
  • D364086

    Decernotinib

    JAK3 inhibitor.

    ≥99%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only